Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Algernon Pharmaceuticals (AGNPF)
OTHER OTC:AGNPF
Algernon Pharmaceuticals (AGNPF) Ownership - Who Owns Algernon Pharmaceuticals?
72 Followers
Algernon Pharmaceuticals (AGNPF) Ownership Overview
47.32% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
52.68% Public Companies and
Individual Investors
The ownership structure of Algernon Pharmaceuticals (AGNPF) stock is a mix of institutional, retail and individual investors. Approximately 0.00% of the company’s stock is owned by Institutional Investors, 47.32% is owned by Insiders and 52.68% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 28, 2024 | Christopher Joseph Moreau Chief Executive Officer | xxxxxxxxxxxxx | C$2145 |
| Jun 07, 2024 | Christopher Joseph Moreau Chief Executive Officer | xxxxxxxxxxxxx | C$2030 |
| May 18, 2024 | Christopher Joseph Moreau Chief Executive Officer | xxxxxxxxxxxxx | C$4335 |
| May 18, 2024 | Christopher Bryan Vice President Research & Operations | xxxxxxxxxxxxx | C$2870 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,030,171 | Insider | 32.19% | 639,746 | |
| 1,108,002 | Insider | 5.07% | 100,828 | |
| 810,992 | Insider | 3.71% | 73,800 | |
| 431,332 | Insider | 1.97% | 39,251 | |
| 216,000 | Insider | 0.99% | 19,656 | |
| 173,180 | Insider | 0.79% | 15,759 | |
| 143,722 | Insider | 0.66% | 13,079 | |
| 125,000 | Insider | 0.57% | 11,375 | |
| 114,760 | Insider | 0.53% | 10,443 | |
| 80,500 | Insider | 0.37% | 7,326 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Algernon Pharmaceuticals (AGNPF)?
According to the latest TipRanks data, approximately 0.00% of the company's stock is held by institutional investors, 47.32% is held by insiders, and 52.68% is held by retail investors.
What percentage of Algernon Pharmaceuticals (AGNPF) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.00% of Algernon Pharmaceuticals (AGNPF) stock is held by institutional investors.
What percentage of Algernon Pharmaceuticals (AGNPF) stock is held by retail investors?
According to the latest TipRanks data, approximately 52.68% of Algernon Pharmaceuticals (AGNPF) stock is held by retail investors.
Who owns the most shares of Algernon Pharmaceuticals (AGNPF)?
Kulwant Singh Malhi owns the most shares of Algernon Pharmaceuticals (AGNPF).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.